peripheral arterial disease, ischemia
Conditions
Interventions
A daily application will be made of electrotherapy with transcutaneous electrical nerve stimulation (TENS) or placebo TENS for 20 uninterrupted minutes, on two consecutive days. Experimental group: 3
Device
D26.660
Sponsors
Universidade Federal de Minas Gerais
Hospital Risoleta Tolentino Neves
Eligibility
Age
18 Years to 102 Years
Inclusion criteria
Inclusion criteria: 72 hospitalized patients; diagnosed with critical ischemia of the lower limbs; of both genders; aged over 18; with ischemic rest pain in the lower limbs; who are waiting for vascular surgery.
Exclusion criteria
Exclusion criteria: Patients with contraindication for application of electrotherapy; patients who have already undergone therapy with transelectrical nerve stimulation prior to the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the reduction in pain after the intervention, measured by the Visual Analogue Scale and the McGill Pain Questionnaire, showing a reduction in the scores after the intervention comparing to those measured before. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome is the reduction of pain medications, observed by the drugs prescription registered on medical records before in relation to those registered after the intervention,through the dosage reduction of analgesics after the intervention. | — |
Countries
Brazil
Contacts
Public ContactLigia Cisneros
Universidade Federal de Minas Gerais
Outcome results
None listed